INBX
Closed
Inhibrx inc
14.67
+0.40 (+2.80%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 14.27
Day's Range: 13.97 - 15.18
Send
sign up or login to leave a comment!
When Written:
18.245
Inhibrx Inc. is a clinical-stage biotechnology company that focuses on developing therapeutics for the treatment of cancer, autoimmune diseases, and other serious conditions. The company's proprietary platform technology, called INBRX-100, enables the creation of multi-specific antibodies that can simultaneously bind to multiple targets with high specificity and affinity. Inhibrx is developing a pipeline of product candidates that target various diseases, including solid tumors, hematologic malignancies, and autoimmune disorders. The company was founded in 2010 and is headquartered in La Jolla, California.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








